Log In
BCIQ
Print this Print this
 

Cabotegravir (S/GSK1265744)

  Manage Alerts
Collapse Summary General Information
Company ViiV Healthcare Ltd.
DescriptionLong-acting parenteral integrase strand transfer inhibitor (INSTI)
Molecular Target HIV integrase
Mechanism of ActionHIV integrase inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase III
Standard IndicationHIV / AIDS
Indication DetailsMaintenance treatment of HIV-1 infection; Treat and prevent HIV infection; Treat HIV infection
Regulatory Designation
PartnerShionogi & Co. Ltd.;
ViiV Healthcare Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

0

0

0


 Deals Details
Get a free BioCentury trial today